The Combination of IL-6, PLR and Nail Psoriasis: Screen for the Early Diagnosis of Psoriatic Arthritis

References

• Scher JU, Ogdie A, Merola JF, Ritchlin C. Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition. Nat Rev Rheumatol. 2019;15(3):153–166. doi:10.1038/s41584-019-0175-0
   PubMed Web of Science ®Google Scholar
• Mease PJ, Gladman DD, Papp KA, et al. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. J Am Acad Dermatol. 2013;69(5):729–735. doi:10.1016/j.jaad.2013.07.023
   PubMed Web of Science ®Google Scholar
• Tillett W, Charlton R, Nightingale A, et al. Interval between onset of psoriasis and psoriatic arthritis comparing the UK Clinical Practice Research Datalink with a hospital-based cohort. Rheumatology. 2017;56(12):2109–2113. doi:10.1093/rheumatology/kex323
   PubMed Web of Science ®Google Scholar
• Haroon M, Gallagher P, FitzGerald O. Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis. 2015;74(6):1045–1050. doi:10.1136/annrheumdis-2013-204858
   PubMed Web of Science ®Google Scholar
• Chiricozzi A, Romanelli P, Volpe E, Borsellino G, Romanelli M. Scanning the immunopathogenesis of psoriasis. Int J Mol Sci. 2018;19(1):179. doi:10.3390/ijms19010179
   PubMed Web of Science ®Google Scholar
• FitzGerald O, Ogdie A, Chandran V, et al. Psoriatic arthritis. Nat Rev Dis Primers. 2021;7(1):59. doi:10.1038/s41572-021-00293-y
   PubMed Web of Science ®Google Scholar
• Mease PJ, Gottlieb AB, Berman A, et al. The efficacy and safety of clazakizumab, an anti-interleukin-6 monoclonal antibody, in a Phase IIB study of adults with active psoriatic arthritis. Arthritis Rheumatol. 2016;68(9):2163–2173. doi:10.1002/art.39700
   PubMed Web of Science ®Google Scholar
• Stober C. Pathogenesis of psoriatic arthritis. Best Pract Res Clin Rheumatol. 2021;35(2):101694. doi:10.1016/j.berh.2021.101694
   PubMed Web of Science ®Google Scholar
• Alenius GM, Eriksson C, Rantapaa Dahlqvist S. Interleukin-6 and soluble interleukin-2 receptor alpha-markers of inflammation in patients with psoriatic arthritis? Clin Exp Rheumatol. 2009;27(1):120–123.
   PubMed Web of Science ®Google Scholar
• Chandran V. Soluble biomarkers may differentiate psoriasis from psoriatic arthritis. J Rheumatol Suppl. 2012;89:65–66. doi:10.3899/jrheum.120247
   PubMedGoogle Scholar
• Fitzgerald O, Chandran V. Update on biomarkers in psoriatic arthritis: a report from the GRAPPA 2010 annual meeting. J Rheumatol. 2012;39(2):427–430. doi:10.3899/jrheum.111241
   PubMedGoogle Scholar
• Abdelaal NH, Elhefnawy NG, Abdulmonem SR, Sayed S, Saleh NA, Saleh MA. Evaluation of the expression of the stromal cell-derived factor-1 alpha (CXCL 12) in psoriatic patients after treatment with Methotrexate. J Cosmet Dermatol. 2020;19(1):253–258. doi:10.1111/jocd.12994
   PubMed Web of Science ®Google Scholar
• El-Leithy S, Sherif N, El-Arousy NH, El-Hilaly R, Shakweer MM. Cutaneous immunohistochemical expression of interleukin-23 receptor (IL-23R) in psoriasis and psoriatic arthritis patients: relation to musculoskeletal ultrasound findings. Egypt Rheumatol. 2020;42(4):313–318. doi:10.1016/j.ejr.2020.02.007
   Web of Science ®Google Scholar
• Bos F, Capsoni F, Molteni S, et al. Differential expression of interleukin-2 by anti-CD3-stimulated peripheral blood mononuclear cells in patients with psoriatic arthritis and patients with cutaneous psoriasis. Clin Exp Dermatol. 2014;39(3):385–390. doi:10.1111/ced.12251
   PubMed Web of Science ®Google Scholar
• Szentpetery A, Heffernan E, Gogarty M, et al. Abatacept reduces synovial regulatory T-cell expression in patients with psoriatic arthritis. Arthritis Res Ther. 2017;19(1):158. doi:10.1186/s13075-017-1364-3
   PubMedGoogle Scholar
• Fan Z, Wang L, Jiang H, Lin Y, Wang Z. Platelet dysfunction and its role in the pathogenesis of psoriasis. Dermatology. 2021;237(1):56–65. doi:10.1159/000505536
   PubMed Web of Science ®Google Scholar
• Shao S, Fang H, Dang E, et al. Neutrophil extracellular traps promote inflammatory responses in psoriasis via activating epidermal TLR4/IL-36R crosstalk. Front Immunol. 2019;10:746. doi:10.3389/fimmu.2019.00746
   PubMed Web of Science ®Google Scholar
• Kim DS, Shin D, Lee MS, et al. Assessments of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in Korean patients with psoriasis vulgaris and psoriatic arthritis. J Dermatol. 2016;43(3):305–310. doi:10.1111/1346-8138.13061
   PubMed Web of Science ®Google Scholar
• Gladman DD. Early psoriatic arthritis. Rheum Dis Clin North Am. 2012;38(2):373–386. doi:10.1016/j.rdc.2012.05.005
   PubMed Web of Science ®Google Scholar
• Alinaghi F, Calov M, Kristensen LE, et al. Prevalence of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational and clinical studies. J Am Acad Dermatol. 2019;80(1):251–265 e219. doi:10.1016/j.jaad.2018.06.027
   PubMed Web of Science ®Google Scholar
• Karmacharya P, Chakradhar R, Ogdie A. The epidemiology of psoriatic arthritis: a literature review. Best Pract Res Clin Rheumatol. 2021;35(2):101692. doi:10.1016/j.berh.2021.101692
   PubMed Web of Science ®Google Scholar
• Ritchlin CT, Colbert RA, Gladman DD, Longo DL. Psoriatic Arthritis. N Engl J Med. 2017;376(10):957–970. doi:10.1056/NEJMra1505557
   PubMed Web of Science ®Google Scholar
• Yang Q, Qu L, Tian H, et al. Prevalence and characteristics of psoriatic arthritis in Chinese patients with psoriasis. J Eur Acad Dermatol Venereol. 2011;25(12):1409–1414. doi:10.1111/j.1468-3083.2011.03985.x
   PubMed Web of Science ®Google Scholar
• Mulder MLM, van Hal TW, Wenink MH, et al. Clinical, laboratory, and genetic markers for the development or presence of psoriatic arthritis in psoriasis patients: a systematic review. Arthritis Res Ther. 2021;23(1):168. doi:10.1186/s13075-021-02545-4
   PubMed Web of Science ®Google Scholar
• Castellanos-Gonzalez M, Joven BE, Sanchez J, et al. Nail involvement can predict enthesopathy in patients with psoriasis. J Dtsch Dermatol Ges. 2016;14(11):1102–1107. doi:10.1111/ddg.12989
   Web of Science ®Google Scholar
• Fiocco U, Sfriso P, Oliviero F, et al. Synovial effusion and synovial fluid biomarkers in psoriatic arthritis to assess intraarticular tumor necrosis factor-α blockade in the knee joint. Arthritis Res Ther. 2010;12(4):R148. doi:10.1186/ar3090
   PubMed Web of Science ®Google Scholar
• Pietrzak A, Chabros P, Grywalska E, et al. Serum concentration of interleukin 6 is related to inflammation and dyslipidemia in patients with psoriasis. Postepy Dermatol Alergol. 2020;37(1):41–45. doi:10.5114/ada.2018.78028
   PubMed Web of Science ®Google Scholar
• Ogata A, Kumanogoh A, Tanaka T. Pathological role of interleukin-6 in psoriatic arthritis. Arthritis. 2012;2012:713618. doi:10.1155/2012/713618
   PubMedGoogle Scholar
• Madureira P, Pimenta SS, Bernardo A, Brito JS, Bernardes M, Costa L. Off-label use of tocilizumab in psoriatic arthritis: case series and review of the literature. Acta Reumatol Port. 2016;41(3):251–255.
   PubMed Web of Science ®Google Scholar
• FitzGerald O. Spondyloarthropathies: IL-6 blockade in psoriatic arthritis - a new therapeutic option? Nat Rev Rheumatol. 2016;12(6):318–319. doi:10.1038/nrrheum.2016.84
   PubMed Web of Science ®Google Scholar
• Wang WM, Jin HZ. Role of Neutrophils in Psoriasis. J Immunol Res. 2020;2020:3709749. doi:10.1155/2020/3709749
   PubMed Web of Science ®Google Scholar
• Holinstat M. Normal platelet function. Cancer Metastasis Rev. 2017;36(2):195–198. doi:10.1007/s10555-017-9677-x
   PubMed Web of Science ®Google Scholar
• Asahina A, Kubo N, Umezawa Y, Honda H, Yanaba K, Nakagawa H. Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and mean platelet volume in Japanese patients with psoriasis and psoriatic arthritis: response to therapy with biologics. J Dermatol. 2017;44(10):1112–1121. doi:10.1111/1346-8138.13875
   PubMed Web of Science ®Google Scholar
• Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN. Psoriasis. Lancet. 2021;397(10281):1301–1315. doi:10.1016/s0140-6736(20)32549-6
   PubMed Web of Science ®Google Scholar
• Perez-Chada LM, Merola JF. Comorbidities associated with psoriatic arthritis: review and update. Clin Immunol. 2020;214:108397. doi:10.1016/j.clim.2020.108397
   PubMed Web of Science ®Google Scholar
• Di Y, Wang J, Chen Y, et al. Elevated interleukin 1β and interleukin 6 levels in the serum of children with hyperuricemia. J Clin Rheumatol. 2018;24(2):65–69. doi:10.1097/RHU.0000000000000611
   PubMed Web of Science ®Google Scholar
• Chen M, Zhu Y, Wang J, Wang G, Wu Y. The predictive value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio levels of diabetic peripheral neuropathy. J Pain Res. 2021;14:2049–2058. doi:10.2147/JPR.S304595
   PubMed Web of Science ®Google Scholar